Clinical Trial Update: An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now

View source ↗

Summary

A completed clinical trial evaluating the multi-target stool DNA test (Cologuard) for colorectal cancer screening in average-risk individuals aged 45-49; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cologuard (multi-target stool DNA test for colorectal cancer)

Snippet

Sponsor: Exact Sciences Corporation | Conditions: Colorectal Cancer | Status: COMPLETED | Results posted: 2021-06-04